Compare, Analyse Aurobindo Pharma with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs TEVA PHARMA (Israel) - Comparison Results

AUROBINDO PHARMA     Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AUROBINDO PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-19
TEVA PHARMA
Dec-13
AUROBINDO PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs8303,080-   
Low Rs5272,675-   
Sales per share (Unadj.) Rs333.91,767.4-  
Earnings per share (Unadj.) Rs40.4110.4-  
Cash flow per share (Unadj.) Rs51.8253.3-  
Dividends per share (Unadj.) Rs2.5096.65-  
Dividend yield (eoy) %0.43.4 11.0%  
Book value per share (Unadj.) Rs237.11,963.3-  
Shares outstanding (eoy) m585.91848.00-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.01.6 124.8%   
Avg P/E ratio x16.826.1 64.5%  
P/CF ratio (eoy) x13.111.4 115.4%  
Price / Book Value ratio x2.91.5 195.3%  
Dividend payout %6.287.5 7.1%   
Avg Mkt Cap Rs m397,5692,440,052 16.3%   
No. of employees `00017.944.9 39.7%   
Total wages/salary Rs m25,8490-   
Avg. sales/employee Rs Th10,956.933,346.7 32.9%   
Avg. wages/employee Rs Th1,447.70-   
Avg. net profit/employee Rs Th1,324.32,083.1 63.6%   
INCOME DATA
Net Sales Rs m195,6361,498,767 13.1%  
Other income Rs m1,5530-   
Total revenues Rs m197,1891,498,767 13.2%   
Gross profit Rs m39,519410,438 9.6%  
Depreciation Rs m6,680121,147 5.5%   
Interest Rs m2,62629,438 8.9%   
Profit before tax Rs m31,767259,853 12.2%   
Minority Interest Rs m271,180 2.3%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-881-170,579 0.5%   
Tax Rs m7,269-3,173 -229.1%   
Profit after tax Rs m23,64593,627 25.3%  
Gross profit margin %20.227.4 73.8%  
Effective tax rate %22.9-1.2 -1,874.1%   
Net profit margin %12.16.2 193.5%  
BALANCE SHEET DATA
Current assets Rs m153,6451,012,262 15.2%   
Current liabilities Rs m120,429882,778 13.6%   
Net working cap to sales %17.08.6 196.5%  
Current ratio x1.31.1 111.3%  
Inventory Days Days13591 148.9%  
Debtors Days Days6496 66.4%  
Net fixed assets Rs m103,909489,530 21.2%   
Share capital Rs m5863,689 15.9%   
"Free" reserves Rs m138,3220-   
Net worth Rs m138,9081,664,846 8.3%   
Long term debt Rs m1,800766,353 0.2%   
Total assets Rs m264,5443,425,163 7.7%  
Interest coverage x13.19.8 133.3%   
Debt to equity ratio x00.5 2.8%  
Sales to assets ratio x0.70.4 169.0%   
Return on assets %9.93.6 276.4%  
Return on equity %17.05.6 302.7%  
Return on capital %23.84.9 483.4%  
Exports to sales %49.60-   
Imports to sales %18.80-   
Net fx Rs m56,7270-   
CASH FLOW
From Operations Rs m16,220238,826 6.8%  
From Investments Rs m-28,768-84,626 34.0%  
From Financial Activity Rs m19,191-286,488 -6.7%  
Net Cashflow Rs m6,656-132,288 -5.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 73.78 Rs / USD

Compare AUROBINDO PHARMA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare AUROBINDO PHARMA With: ALEMBIC PHARMA  UNICHEM LAB  STRIDES PHARMA SCIENCE  AJANTA PHARMA  DIVIS LABORATORIES  



Today's Market

Sensex Ends 272 Points Higher; Hindalco, Hero MotoCorp & Wipro Surge Over 4%(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views On News

J.B.CHEMICALS at All Time High; BSE HEALTHCARE Index Up 0.2% (Market Updates)

May 6, 2021 | Updated on May 6, 2021

J.B.CHEMICALS share price has hit an all time high at Rs 1,460 (up 2.8%). The BSE HEALTHCARE Index is up by 0.2%. Among the top gainers in the BSE HEALTHCARE Index today are J.B.CHEMICALS (up 2.8%) and ABBOTT INDIA (up 0.5%). The top losers include IPCA LABS and DIVIS LABORATORIES .

AUROBINDO PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 25.6% (Quarterly Result Update)

Sep 15, 2020 | Updated on Sep 15, 2020

For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

AUROBINDO PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Nov 6, 2019 | Updated on Nov 6, 2019

Here's an analysis of the annual report of AUROBINDO PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

More Views on News

Most Popular

Power Grid's InvIT IPO: Key Points to Consider (Company Info)

Apr 23, 2021

In this article, we discuss the key reasons why the stock of Power Grid was in focus today.

Time to Buy Smallcaps? (Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners (Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

This Fund Manager Has Taken the World by Storm. Will You Invest With Her? (Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Learn: How to Potentially Accumulate Rs 7 Crore in Wealth Over the Long-term
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

AUROBINDO PHARMA SHARE PRICE


May 6, 2021 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA - WOCKHARDT COMPARISON

COMPARE AUROBINDO PHARMA WITH

FEATURED VIDEOS

The 'Big' Money is in this 'Small' Detail

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

More Featured Videos

MARKET STATS